• Biohit Healthcare (Hefei) sold 650,000 Series A shares in Biohit on October 27, 2026.
• Its stake fell to 18.38% from 22.67%, crossing below the 20% threshold.
• Voting rights dropped to 3.9% from 22.02%, below the 5% threshold.
• The shareholder retains 2,795,415 Series B shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biohit Oyj published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.